# Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%

> **NCT03351842** · PHASE2 · RECRUITING · sponsor: **Shanghai Pulmonary Hospital, Shanghai, China** · enrollment: 460 (estimated)

## Conditions studied

- Chemotherapy, Adjuvant
- Lung Adenocarcinoma, Stage I
- Treatment
- Histological Type of Neoplasm

## Interventions

- **DRUG:** cis Platinum/Carboplatin, Pemetrexed Disodium
- **PROCEDURE:** Undergo surgery

## Key facts

- **NCT ID:** NCT03351842
- **Lead sponsor:** Shanghai Pulmonary Hospital, Shanghai, China
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2017-09-01
- **Primary completion:** 2019-09-01
- **Final completion:** 2024-09-01
- **Target enrollment:** 460 (ESTIMATED)
- **Last updated:** 2017-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03351842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03351842, "Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03351842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*